
Buy PTD-DBM Research Peptide
Supplied as a lyophilized powder and independently verified to ≥98% purity by HPLC and MS-UPLC analysis.

Buy PTD-DBM Research Peptide
Supplied as a lyophilized powder and independently verified to ≥98% purity by HPLC and MS-UPLC analysis.
HPLC Verified
≥98% purity
Lyophilised
Powder format
Express Shipping
Cold-chain included
COA Available
Every batch
Next batch coming soon
This compound is temporarily out of stock. Check back soon or contact us for a restock estimate.
HPLC Verified
≥98% purity
Lyophilised
Powder format
Express Shipping
Cold-chain included
COA Available
Every batch
Next batch coming soon
This compound is temporarily out of stock. Check back soon or contact us for a restock estimate.
Verify Batch
Lot-level COA, Batch DF/PTD/062026
What is PTD-DBM?
PTD-DBM is a cell-entering peptide that switches on the Wnt signaling pathway by blocking CXXC5, a protein that holds the pathway back by latching onto Dishevelled. It is studied in animal research for its effects on hair-follicle growth. It is studied in animal research for its effects on hair-follicle growth.
- A cell-entering peptide that blocks the Dvl-CXXC5 brake on the Wnt pathway
- Studied for its effects on Wnt signaling in hair-follicle research models
- Animal studies looked at new hair-follicle growth after it was applied to the skin
- Used as a research tool for Wnt-pathway control of hair-follicle development
For research use only. Not approved for human therapeutic use.
PTD-DBM (Protein Transduction Domain – Dishevelled Binding Motif) is a synthetic chimeric cell-penetrating peptide with a molecular weight of 3082.64 g/mol. Its structure consists of a cell-penetrating protein transduction domain (PTD) fused to a Dishevelled (Dvl) binding motif derived from CXXC5, an intracellular negative-feedback regulator of the Wnt/β-catenin signaling pathway. The PTD component enables the peptide to traverse cell membranes without requiring receptor-mediated endocytosis, while the Dvl-binding motif provides the functional interaction domain that competes with endogenous CXXC5 for binding to Dishevelled. Produced via solid-phase peptide synthesis, PTD-DBM is associated with Wnt/β-catenin pathway modulation.
PTD-DBM has been investigated as a tool compound for releasing the CXXC5-mediated negative-feedback brake on Wnt/β-catenin signaling. CXXC5 acts as a negative-feedback regulator of the Wnt/β-catenin pathway by binding to the Dishevelled protein, and PTD-DBM was designed to disrupt this CXXC5–Dishevelled interaction, thereby de-repressing pathway activity. Published studies have documented that PTD-DBM competitively blocks the CXXC5–Dishevelled interaction, stabilizing β-catenin and activating Wnt/β-catenin target-gene signaling, and that topical co-application of the peptide with the GSK-3β inhibitor valproic acid synergistically accelerated cutaneous wound healing [1]. Further in vivo work has documented that disrupting the CXXC5–Dishevelled interaction with the competitor peptide activated the Wnt/β-catenin pathway and accelerated hair regrowth and wound-induced hair follicle neogenesis in mouse models, with co-administration of the GSK-3β inhibitor valproic acid further increasing the hair-regrowth response [2], making PTD-DBM a reference compound in preclinical research examining CXXC5–Dishevelled-directed activation of Wnt/β-catenin signaling in skin wound-healing and hair-follicle regeneration models.
PTD-DBM is produced to research-grade standards and independently verified by third-party HPLC and MS-UPLC analysis before dispatch. Vials are vacuum sealed and stored in a temperature controlled, monitored cold storage system. Certificates of Analysis are available to view and download directly on the product page.
Sold strictly for in vitro research purposes only. Not for human consumption. Intended for use by qualified researchers in laboratory settings only.
References
Scientific Review

Dr. Martina Rossi, PhD
Scientific Contributor and Reviewer
Reviewed for scientific accuracy, 11 August 2026
Lyophilised powder: store at -20 °C or below, away from light and moisture. Once reconstituted in an appropriate laboratory diluent (e.g. sterile water, PBS, or assay buffer), store at 2–8 °C and use within the validated period for your protocol. Do not refreeze.
What Researchers Say
Sign in to leave a reviewNo reviews yet. Be the first to share your research experience.
Frequently Asked Questions
Select Size
Get notified when this batch is released
Enter your email and we'll let you know as soon as this product is available again.
Quality Guaranteed
Every batch is HPLC-tested to ≥98% purity. Certificate of Analysis available on this page; MSDS available on request.






